Cargando…
Ultra-pure platelet isolation from canine whole blood
BACKGROUND: Several research applications involving platelets, such as proteomic and transcriptomic analysis, require samples with very low numbers of contaminating leukocytes, which have considerably higher RNA and protein content than platelets. We sought to develop a platelet purification protoco...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720268/ https://www.ncbi.nlm.nih.gov/pubmed/23866028 http://dx.doi.org/10.1186/1746-6148-9-144 |
_version_ | 1782277949505929216 |
---|---|
author | Trichler, Shauna A Bulla, Sandra C Thomason, John Lunsford, Kari V Bulla, Camilo |
author_facet | Trichler, Shauna A Bulla, Sandra C Thomason, John Lunsford, Kari V Bulla, Camilo |
author_sort | Trichler, Shauna A |
collection | PubMed |
description | BACKGROUND: Several research applications involving platelets, such as proteomic and transcriptomic analysis, require samples with very low numbers of contaminating leukocytes, which have considerably higher RNA and protein content than platelets. We sought to develop a platelet purification protocol that would minimize contamination, involve minimal centrifugation steps, and yield highly pure platelet samples derived from low volume whole blood samples from healthy dogs. RESULTS: Using an optimized OptiPrep density gradient technique, platelet recovery was 51.56% with 99.99% platelet purity and leukocyte contamination of 100 leukocytes per 10(8) platelets, on average. Platelet samples were subjected to additional purification with CD45-labeled Dynabeads after density barrier centrifugation resulting in a 95-fold depletion of residual leukocytes. Platelets purified using these methods remained inactivated as assessed by Annexin V and P-selectin labeling with flow cytometry. CONCLUSIONS: The use of OptiPrep density gradient is a quick method for obtaining highly purified platelet samples from low volumes of canine whole blood with minimal contamination. Additional depletion of residual leukocytes can be achieved using CD45-labeled beads. These platelet samples can then be used for many downstream applications that require ultra-pure platelet samples such as RNA and protein analysis. |
format | Online Article Text |
id | pubmed-3720268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37202682013-07-24 Ultra-pure platelet isolation from canine whole blood Trichler, Shauna A Bulla, Sandra C Thomason, John Lunsford, Kari V Bulla, Camilo BMC Vet Res Methodology Article BACKGROUND: Several research applications involving platelets, such as proteomic and transcriptomic analysis, require samples with very low numbers of contaminating leukocytes, which have considerably higher RNA and protein content than platelets. We sought to develop a platelet purification protocol that would minimize contamination, involve minimal centrifugation steps, and yield highly pure platelet samples derived from low volume whole blood samples from healthy dogs. RESULTS: Using an optimized OptiPrep density gradient technique, platelet recovery was 51.56% with 99.99% platelet purity and leukocyte contamination of 100 leukocytes per 10(8) platelets, on average. Platelet samples were subjected to additional purification with CD45-labeled Dynabeads after density barrier centrifugation resulting in a 95-fold depletion of residual leukocytes. Platelets purified using these methods remained inactivated as assessed by Annexin V and P-selectin labeling with flow cytometry. CONCLUSIONS: The use of OptiPrep density gradient is a quick method for obtaining highly purified platelet samples from low volumes of canine whole blood with minimal contamination. Additional depletion of residual leukocytes can be achieved using CD45-labeled beads. These platelet samples can then be used for many downstream applications that require ultra-pure platelet samples such as RNA and protein analysis. BioMed Central 2013-07-17 /pmc/articles/PMC3720268/ /pubmed/23866028 http://dx.doi.org/10.1186/1746-6148-9-144 Text en Copyright © 2013 Trichler et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Article Trichler, Shauna A Bulla, Sandra C Thomason, John Lunsford, Kari V Bulla, Camilo Ultra-pure platelet isolation from canine whole blood |
title | Ultra-pure platelet isolation from canine whole blood |
title_full | Ultra-pure platelet isolation from canine whole blood |
title_fullStr | Ultra-pure platelet isolation from canine whole blood |
title_full_unstemmed | Ultra-pure platelet isolation from canine whole blood |
title_short | Ultra-pure platelet isolation from canine whole blood |
title_sort | ultra-pure platelet isolation from canine whole blood |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720268/ https://www.ncbi.nlm.nih.gov/pubmed/23866028 http://dx.doi.org/10.1186/1746-6148-9-144 |
work_keys_str_mv | AT trichlershaunaa ultrapureplateletisolationfromcaninewholeblood AT bullasandrac ultrapureplateletisolationfromcaninewholeblood AT thomasonjohn ultrapureplateletisolationfromcaninewholeblood AT lunsfordkariv ultrapureplateletisolationfromcaninewholeblood AT bullacamilo ultrapureplateletisolationfromcaninewholeblood |